Advances in the treatment of hemolytic anemia

Clinical Focus ›› 2014, Vol. 29 ›› Issue (10): 1087-1.09011e+007.

WU Yu;XU Juan

CLC Number:

WU Yu;XU Juan. Advances in the treatment of hemolytic anemia[J]. Clinical Focus, 2014, 29(10): 1087-1.09011e+007.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

[1]	Fu Shuxia1, Fu Shuli2. Advances in the treatment of idiopathic membranous nephropathy [J]. Clinical Focus, 2019, 34(12): 1061-1065.
[2]	Li Yue， Qian Jiaming. Recent advances of immunosuppressive therapy in inflammatory bowel disease [J]. Clinical Focus, 2016, 31(8): 824-827.
[3]	Gao Lixia. Diagnosis and treatment advances of IgG4related disease [J]. Clinical Focus, 2016, 31(5): 501-505.
[4]	Li Yingmei;Sun Hui. Current status of diagnosis and treatment of autoimmune hemolytic anemia [J]. Clinical Focus, 2015, 30(10): 1087-1091.
[5]	HUANG Zhi-fang;LI Xin-lun;LI Hong-xia;LUN Li-de. Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus [J]. Clinical Focus, 2014, 29(11): 1243-1245.
[6]	YE Li;TONG Hong-yan. Standardized and novel treatments for patients with myelodysplastic syndromes:an update [J]. Clinical Focus, 2014, 29(10): 1095-1099.
[7]	PENG Jun. Advances in the treatment of refractory/relapsed immune thrombocytopenia [J]. Clinical Focus, 2014, 29(10): 1091-1094.
[8]	WANG Lu;HAN Bing. Recent progresses in the treatment of aplastic anemia [J]. Clinical Focus, 2014, 29(10): 1083-1086.

PDF (PC)